Beth L. Abramson, MD, FACC

General Statement of Disclosure:

OTHER FINANCIAL BENEFIT: Amgen Inc.(SIGNIFICANT), Bayer Healthcare Pharmaceuticals(SIGNIFICANT), Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), hls therapeutics(SIGNIFICANT), Novartis Corporation(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT), Janssen Pharmaceuticals, Inc(SIGNIFICANT)

View Full Disclosure